ADX:JULPHAR (United Arab Emirates)  
Gulf Pharmaceutical Industries PSC logo

Gulf Pharmaceutical Industries PSC

د.إ 1.22 (-0.81%) Oct 5
P/E:
67.78
P/B:
1.49
Market Cap:
د.إ 1.41B ($ 383.70M)
Enterprise V:
د.إ 2.12B ($ 577.95M)
Volume:
4.60K
Avg Vol (2M):
200.95K
Volume:
4.60K
Market Cap د.إ:
1.41B
Market Cap $:
383.70M
PE Ratio:
67.78
Avg Vol (2-Month):
200.95K
Enterprise Value د.إ:
2.12B
Enterprise Value $:
577.95M
PB Ratio:
1.49
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company along with its subsidiaries is engaged in manufacturing & selling medicines, drugs, and other types of pharmaceutical & medical compounds including, cosmetic compounds. It operates in three segments: Manufacturing, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 0.19
Equity-to-Asset 0.39
Debt-to-Equity 0.93
Debt-to-EBITDA 5.31
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.54
Distress
Grey
Safe
Beneish M-Score -1.8
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 43.91
9-Day RSI 39.58
14-Day RSI 38.41
6-1 Month Momentum % -7.19
12-1 Month Momentum % -27.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.27
Quick Ratio 1.29
Cash Ratio 0.26
Days Inventory 193.19
Days Sales Outstanding 108.61
Days Payable 144.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate -100
3-Year Average Share Buyback Ratio -16.3

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil د.إ) 1,595
EPS (TTM) (د.إ) 0.018
Beta 0
Volatility % 28.19
14-Day RSI 38.41
14-Day ATR (د.إ) 0.014323
20-Day SMA (د.إ) 1.2625
12-1 Month Momentum % -27.53
52-Week Range (د.إ) 1.19 - 2.1
Shares Outstanding (Mil) 1,155.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gulf Pharmaceutical Industries PSC Filings

Document Form Filing Date
No Filing Data

Gulf Pharmaceutical Industries PSC Analysis

Share your research